SINOPHARM ONLINE
Sinopharm Online has a pharmaceutical retail platform to provide users with online medication consultation, medical and health management consulting services, etc. The main sales cover Chinese and Western medicines and health products. , medical equipment, Chinese medicine
SINOPHARM ONLINE
Industry:
Pharmaceutical Retail
Founded:
2015-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.sinopharm.com
Total Employee:
251+
Status:
Active
Total Funding:
62.22 M USD
Technology used in webpage:
IPhone / Mobile Compatible SPF Domain Not Resolving IPv6 ASP.NET Apple Mobile Web App Capable IIS Apple Mobile Web App Status Bar Style Japanese Yen Java EE
Current Employees Featured
Investors List
Galaxy Yuanhui Investment
Galaxy Yuanhui Investment investment in Series B - Sinopharm Online
Ample Harvest Finance
Ample Harvest Finance investment in Series B - Sinopharm Online
ShenZhen GTJA Investment Group
ShenZhen GTJA Investment Group investment in Series B - Sinopharm Online
V-Capital
V-Capital investment in Series B - Sinopharm Online
Lang Sheng Investment
Lang Sheng Investment investment in Series A - Sinopharm Online
YF Capital
YF Capital investment in Series A - Sinopharm Online
Fosun Pharma
Fosun Pharma investment in Angel Round - Sinopharm Online
Official Site Inspections
http://www.sinopharm.com Semrush global rank: 1.78 M Semrush visits lastest month: 12.97 K
Unable to get host informations!!!
More informations about "Sinopharm Online"
About Sinopharm
Sinopharm is a globally leading company in the healthcare sector in terms of scale, performance and comprehensive strength. With a primary focus on life & health, the company owns a …See details»
Sinopharm Group - Wikipedia
The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. It completed Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants. The BIBP vaccine shares similar technology with CoronaVac and Covaxin, other inactivated virus vaccines for COVID-19. See details»
Sinopharm Group Co. Ltd.
2022.03.21 Sinopharm Group Announces 2020 Annual Results Accelerate the transformation and About Us +more Sinopharm Group Co. Ltd. (the “Company”, “Sinopharm” or “Sinopharm …See details»
Sinopharm
Address: Sinopharm Plaza, No 20 Zhichun Road, Haidian district, Beijing Postcode: 100191 Tel: 86-10-82287727 Fax: 86-10-62033332See details»
Group Introduction_Who are we_CHINA SINOPHARM …
The Sinopharm COVID-19 vaccine has registered in 119 countries, regions, and international organizations, and the vaccination population covers 196 countries. 04 Strategic Leadership. …See details»
Sinopharm Holding - Crunchbase Company Profile & Funding
Sinopharm is the largest Chinese medical and healthcare group directly managed by State-owned Assets Supervision and Administration Commission of the State Council (SASAC), with the …See details»
CHINA SINOPHARM INTERNATIONAL CORPORATION
Sinopharm International builds close cooperative relationships with more than 100 world-renowned suppliers of medicine, medical devices and health products, dealing with over 195 …See details»
WHO approves China's Sinopharm vaccine for emergency use
The Sinopharm vaccine joins a list of WHO approved vaccines, in addition to those made by Pfizer, AstraZeneca, Johnson & Johnson and Moderna. "The addition of this vaccine has the …See details»
China's Sinopharm vaccine approved by WHO for global use
May 8, 2021 The COVID-19 vaccine developed by China's Sinopharm has been approved by the World Health Organization (WHO) for "emergency use." This means its safety, efficacy …See details»
WHO panel approves emergency use of China's Sinopharm vaccine
May 7, 2021 The World Health Organization gave emergency use authorization Friday to a COVID-19 vaccine manufactured by China's Sinopharm, potentially paving the way for millions …See details»
Sinopharm update - World Health Organization (WHO)
Mar 7, 2022 Sinopharm update. January 2022. 7 March 2022 | Meeting report. Download (4.6 MB) WHO Team. Immunization, Vaccines and Biologicals (IVB), Strategic Advisory Group of …See details»
WHO lists additional COVID-19 vaccine for emergency use and …
May 7, 2021 WHO today listed the Sinopharm COVID-19 vaccine for emergency use, giving the green light for this vaccine to be rolled out globally. The Sinopharm vaccine is produced by …See details»
Sinopharm: Chinese Covid vaccine gets WHO emergency approval …
The World Health Organization (WHO) has granted emergency approval for a Covid vaccine made by Chinese state-owned company Sinopharm. It is the first vaccine developed by a non …See details»
WHO approval of Sinopharm vaccine set to benefit world …
May 10, 2021 The World Health Organization's approval to give emergency use to the COVID-19 vaccine manufactured by China's Sinopharm has been welcomed by experts and health …See details»
WHO approves emergency use of China's Sinopharm COVID-19 …
May 8, 2021 The World Health Organization (WHO) on Friday approved the emergency use of the vaccine produced by Chinese firm Sinopharm. Observers said that Chinese vaccines are …See details»
What are the Sinopharm and Sinovac vaccines? And how effective …
Jun 21, 2021 Sinopharm’s effectiveness against symptomatic infection in Bahrain was 90%. Data from Chile’s rollout suggests Sinovac is 67% effective in preventing symptomatic COVID …See details»
WHO approves China's Sinopharm vaccine for emergency use
Nov 26, 2024 The World Health Organization announced on Friday it will give emergency use authorization to the COVID-19 vaccine manufactured by China's Sinopharm, which will pave …See details»
The Sinopharm COVID-19 vaccine: What you need to know
Jun 10, 2022 The available data on the COVID-19 vaccine Sinopharm in pregnant women are insufficient to assess either vaccine efficacy or vaccine-associated risks in pregnancy. …See details»